Anti-Igf-1r Monoclonal Antibody Inhibits the Carcinogenicity Activity of Acquired Trastuzumab-Resistant SKOV3

Journal of Ovarian Research - United Kingdom
doi 10.1186/s13048-014-0103-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Safety, Tolerability, and Pharmacokinetics of the Anti-Igf-1r Monoclonal Antibody Figitumumab in Patients With Refractory Adrenocortical Carcinoma

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2009English

A Humanised Anti-Igf-1r Monoclonal Antibody (AVE1642) Enhances Bortezomib-Induced Apoptosis in Myeloma Cells Lacking CD45

British Journal of Cancer
Cancer ResearchOncology
2009English

T-Darpp Activates IGF-1R Signaling to Regulate Glucose Metabolism in Trastuzumab-Resistant Breast Cancer Cells

Clinical Cancer Research
Cancer ResearchOncology
2017English

Anti-Antibody Activity of a Monoclonal Macroglobulin

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1971English

Initial Testing of a Monoclonal Antibody (IMC-A12) Against IGF-1R by the Pediatric Preclinical Testing Program

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2010English

The Anti-erbB3 Antibody MM-121/SAR256212 in Combination With Trastuzumab Exerts Potent Antitumor Activity Against Trastuzumab-Resistant Breast Cancer Cells

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2013English

Beta-Adrenergic Agonist Activity of a Monoclonal Anti-Idiotypic Antibody.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1985English

Anti-Kl-6/Muc1 Monoclonal Antibody Reverses Resistance to Trastuzumab-Mediated Antibody-Dependent Cell-Mediated Cytotoxicity by Capping MUC1

Cancer Letters
Cancer ResearchOncology
2019English

IGF-1R as an Anti-Cancer Target--Trials and Tribulations

Chinese Journal of Cancer
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy